These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31455451)

  • 1. Activity of the sesquiterpene lactone goyazensolide against
    Milagre MM; Branquinho RT; Gonçalves MF; de Assis G; de Oliveira MT; Reis L; Saúde-Guimarães DA; de Lana M
    Parasitology; 2020 Jan; 147(1):108-119. PubMed ID: 31455451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the anti-Trypanosoma cruzi activity in vitro and in vivo of silibinin and silibinin in association to benznidazole.
    Torchelsen FKVDS; Silva TM; Milagre MM; Silva RR; Reis LES; Branquinho RT; Silva GN; de Lana M
    Parasitol Res; 2021 Apr; 120(4):1511-1517. PubMed ID: 33236174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide donor trans-[RuCl([15]aneN)NO] as a possible therapeutic approach for Chagas' disease.
    Guedes PM; Oliveira FS; Gutierrez FR; da Silva GK; Rodrigues GJ; Bendhack LM; Franco DW; Do Valle Matta MA; Zamboni DS; da Silva RS; Silva JS
    Br J Pharmacol; 2010 May; 160(2):270-82. PubMed ID: 20128813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined treatment of heterocyclic analogues and benznidazole upon Trypanosoma cruzi in vivo.
    Batista Dda G; Batista MM; de Oliveira GM; Britto CC; Rodrigues AC; Stephens CE; Boykin DW; Soeiro Mde N
    PLoS One; 2011; 6(7):e22155. PubMed ID: 21814568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lychnopholide in Poly(d,l-Lactide)-
    Branquinho RT; de Mello CGC; Oliveira MT; Reis LES; Vieira PMA; Saúde-Guimarães DA; Mosqueira VCF; de Lana M
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31988096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo drug combination for the treatment of Trypanosoma cruzi infection: A multivariate approach.
    Strauss M; Rodrigues JHS; Lo Presti MS; Bazán PC; Báez AL; Paglini-Oliva P; Nakamura CV; Bustamante JM; Rivarola HW
    Exp Parasitol; 2018 Jun; 189():19-27. PubMed ID: 29726395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo activity of voriconazole and benznidazole combination on trypanosoma cruzi infection models.
    Gulin JEN; Eagleson MA; López-Muñoz RA; Solana ME; Altcheh J; García-Bournissen F
    Acta Trop; 2020 Nov; 211():105606. PubMed ID: 32598923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thioridazine aggravates skeletal myositis, systemic and liver inflammation in Trypanosoma cruzi-infected and benznidazole-treated mice.
    Mendonça AAS; Gonçalves-Santos E; Souza-Silva TG; González-Lozano KJ; Caldas IS; Gonçalves RV; Diniz LF; Novaes RD
    Int Immunopharmacol; 2020 Aug; 85():106611. PubMed ID: 32447223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activities of psilostachyin A and cynaropicrin against Trypanosoma cruzi in vitro and in vivo.
    da Silva CF; Batista Dda G; De Araújo JS; Batista MM; Lionel J; de Souza EM; Hammer ER; da Silva PB; De Mieri M; Adams M; Zimmermann S; Hamburger M; Brun R; Schühly W; Soeiro Mde N
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5307-14. PubMed ID: 23939901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sesquiterpene lactone in nanostructured parenteral dosage form is efficacious in experimental Chagas disease.
    Branquinho RT; Mosqueira VC; de Oliveira-Silva JC; Simões-Silva MR; Saúde-Guimarães DA; de Lana M
    Antimicrob Agents Chemother; 2014; 58(4):2067-75. PubMed ID: 24449777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trypanosoma cruzi benznidazole susceptibility in vitro does not predict the therapeutic outcome of human Chagas disease.
    Moreno M; D'ávila DA; Silva MN; Galvão LM; Macedo AM; Chiari E; Gontijo ED; Zingales B
    Mem Inst Oswaldo Cruz; 2010 Nov; 105(7):918-24. PubMed ID: 21120364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sesquiterpene lactone potentiates the immunomodulatory, antiparasitic and cardioprotective effects on anti-Trypanosoma cruzi specific chemotherapy.
    Gonçalves-Santos E; Vilas-Boas DF; Diniz LF; Veloso MP; Mazzeti AL; Rodrigues MR; Oliveira CM; Fernandes VHC; Novaes RD; Chagas-Paula DA; Caldas IS
    Int Immunopharmacol; 2019 Dec; 77():105961. PubMed ID: 31685438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity profile of two 5-nitroindazole derivatives over the moderately drug-resistant
    Fonseca-Berzal C; da Silva CF; Batista DDGJ; de Oliveira GM; Cumella J; Batista MM; Peres RB; Silva da Gama Nefertiti A; Escario JA; Gómez-Barrio A; Arán VJ; Soeiro MNC
    Parasitology; 2020 Sep; 147(11):1216-1228. PubMed ID: 32530391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant Benznidazole and Suramin Chemotherapy in Mice Infected with a Virulent Strain of Trypanosoma cruzi.
    Santos EC; Novaes RD; Cupertino MC; Bastos DS; Klein RC; Silva EA; Fietto JL; Talvani A; Bahia MT; Oliveira LL
    Antimicrob Agents Chemother; 2015 Oct; 59(10):5999-6006. PubMed ID: 26169419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effects of benznidazole in Swiss mice that are orally inoculated with Trypanosoma cruzi IV strains from the Western Brazilian Amazon.
    Teston APM; Fernandes NS; Abegg CP; de Abreu AP; Sarto MPM; Gomes ML; Toledo MJO
    Exp Parasitol; 2021 Sep; 228():108136. PubMed ID: 34280400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of essential oil of Syzygium aromaticum alone and in combination with benznidazole on murine oral infection with Trypanosoma cruzi IV.
    Zanusso Junior G; Massago M; Kian D; Toledo MJO
    Exp Parasitol; 2018 Feb; 185():92-97. PubMed ID: 29305891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and biological characterization of a highly pathogenic Trypanosoma cruzi strain isolated from a patient with congenital infection.
    Gulin JEN; Bisio M; Rocco DM; Altcheh J; Solana ME; García-Bournissen F
    Exp Parasitol; 2018 Mar; 186():50-58. PubMed ID: 29448038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental benznidazole treatment of Trypanosoma cruzi II strains isolated from children of the Jequitinhonha Valley, Minas Gerais, Brazil, with Chagas disease.
    Oliveira-Silva JC; Machado-de-Assis GF; Oliveira MT; Paiva NC; Araújo MS; Carneiro CM; Martins-Filho OA; Martins HR; Lana Md
    Mem Inst Oswaldo Cruz; 2015 Feb; 110(1):86-94. PubMed ID: 25742267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complexation of the anti-Trypanosoma cruzi drug benznidazole improves solubility and efficacy.
    Nogueira Silva JJ; Pavanelli WR; Gutierrez FR; Alves Lima FC; Ferreira da Silva AB; Santana Silva J; Wagner Franco D
    J Med Chem; 2008 Jul; 51(14):4104-14. PubMed ID: 18570370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo selection of a population of Trypanosoma cruzi and clones resistant to benznidazole.
    Murta SM; Romanha AJ
    Parasitology; 1998 Feb; 116 ( Pt 2)():165-71. PubMed ID: 9509026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.